Otsuka Australia Pharmaceutical Pty Ltd clinical trials

A country office of Otsuka Holdings Co., Ltd.

The registry lists 2 studies whose lead sponsor is Otsuka Australia Pharmaceutical Pty Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 20, 2025.

Status

Active, not recruiting: 1
Completed: 1

Phase

Phase 3: 1

Where

Australia: 2
New Zealand: 1

Registry sponsor names on this page

Otsuka Australia Pharmaceutical Pty Ltd2 studies

Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Otsuka Holdings Co., Ltd. studies →

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic LeukemiaActive, not recruitingNCT05883956Phase 3
Sponsor listed in the registry: Otsuka Australia Pharmaceutical Pty Ltd
Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia QuestionnaireCompletedNCT05817331
Sponsor listed in the registry: Otsuka Australia Pharmaceutical Pty Ltd